학술논문

A Randomized Double-Blinded Placebo Controlled Trial of Clazakizumab for the Treatment of COVID-19 Pneumonia With Hyperinflammation
Document Type
Article
Source
In: Critical Care Medicine. (Critical Care Medicine, 1 September 2022, 50(9):1348-1359)
Subject
Language
English
ISSN
15300293
00903493